Dexamethasone became the latest drug to get attention for its potential in treating COVID, when a study declared this week there were promising results in trials with the drug. But what exactly is ...
MedPage Today on MSN
Some Frail Myeloma Patients Can Quickly Wean Off Dexamethasone, Study Says
A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and ...
David C Gaze is affiliated with The Association for Clinical Biochemistry and Laboratory Medicine; The American Association of Clinical Chemistry; Royal Society of Medicine; Pathological Society of ...
(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) said on Tuesday that it has received approval from the FDA for the Abbreviated New Drug Application for Dexamethasone Tablets USP 1.5mg, 4mg, and 6mg.
https://www.thehindubusinessline.com/markets/stock-markets/zydus-lifesciences-gets-usfda-approvals-for-dexamethasone-tablets/article67824658.ece Copy Zydus ...
Impact of the Number of Treatment Courses on the Clinical Response of Patients Who Receive High-Dose Bolus Interleukin-2 PURPOSE: To investigate the efficacy of dexamethasone as a prophylactic ...
HUNTSVILLE, Ala., May 18, 2011 /PRNewswire/ -- Qualitest Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved dexamethasone elixir, USP, 0.5mg/ 5 mL and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback